Loading...
Author Verified
RCT
Published: Jun 2009
ACE Report #406
Ace Report Cover General Orthopaedics

Golimumab treatment provides superior treatment of rheumatoid arthritis


Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): A multicentre, randomised, double-blind, placebo-controlled, phase III trial

Lancet. 2009 Jul 18;374(9685):210-21. Epub 2009 Jun 26

Contributing Authors: JS Smolen J Kay MK Doyle R Landewé EL Matteson J Wollenhaupt N Gaylis FT Murphy JS Neal Y Zhou S Visvanathan EC Hsia MU Rahman GO-AFTER study investigators

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.